ExLibris header image
SFX Logo
Title: The effect of deprenyl (selegiline) on the natural history of Parkinson's disease
Source:

Science [0036-8075] Tetrud, J W yr:1989


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Ahn, T. "A case of ergoloid mesylate-induced chorea." Movement disorders 21 (2006). Link to Full Text for this item Link to SFX for this item
2. Rascol, O. "Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial." The lancet 365.9463 (2005): 947-54. Link to SFX for this item
3. Myllyl, V. "Selegiline as the primary treatment of Parkinson's disease--a long-term double-blind study." Acta neurologica Scandinavica 95.4 (1997): 211-8. Link to Full Text for this item Link to SFX for this item
4. Burgut, F Tuna T. "Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors." Expert review of neurotherapeutics 5.6 (2005): 811-21. Link to SFX for this item
5. Gill, SS. "Parkinson Disease." Nature medicine 9 (2003): 589-. Link to Full Text for this item Link to SFX for this item
6. In, S. "A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study." Archives of neurology 62.2 (2005): 241-8. Link to SFX for this item
7. Stern, Matthew B B. "Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients." Movement disorders 19.8 (2004): 916-23. Link to Full Text for this item Link to SFX for this item
8. Waters, Cheryl H. "Zydis selegiline reducesoff time in Parkinson's disease patients with motor fluctuations: A 3-month, randomized, placebo-controlled study." Movement disorders 19.4 (2004): 426-32. Link to Full Text for this item Link to SFX for this item
9. Samii, A. "Parkinson's disease." The lancet 365.9459: 1783-1793. Link to SFX for this item
10. Rabey, J M M. "Rasagiline Mesylate, a New Mao-B Inhibitor for the Treatment of Parkinson's Disease: A Double-Blind Study as Adjunctive Therapy to Levodopa." Clinical neuropharmacology 23.6 (2000): 324-330. Link to SFX for this item
11. Sullivan, Fiona M M. "Neuroprotective effects of delayed administration of growth/differentiation factor-5 in the partial lesion model of Parkinson's disease." Experimental Neurology 187.2 (2004): 281-9. Link to SFX for this item
12. Clarke, A. "Selegiline orally disintegrating tablet in the treatment of Parkinson's disease." Therapy 3.3 (2006): 349-356. Link to SFX for this item
13. Heinrich, J. "Aplindore (DAB-452), a high affinity selective dopamine D-2 receptor partial agonist." European Journal of Pharmacology 552.1-3 (2006): 36-45. Link to SFX for this item
14. Agid, Y. "Clinical predictive factors of subthalamic stimulation in Parkinson's disease." Brain 125.3 (2002): 575-83. Link to SFX for this item
15. Pålhagen, S. "Selegiline slows the progression of the symptoms of Parkinson disease." Neurology 66.8 (2006): 1200-6. Link to SFX for this item
16. Olanow, C Warren W. "The scientific basis for the current treatment of Parkinson's disease." Annual review of medicine 55.1 (2004): 41-60. Link to Full Text for this item Link to SFX for this item
17. Freeman, T B B. "Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease." New England Journal of Medicine, The 341.13 (1999): 988-92. Link to SFX for this item
18. Kordower JH, J. "In vivo gene delivery of glial cell line--derived neurotrophic factor for Parkinson's disease." Annals of neurology 53 Suppl 3.Supplement 3 (2003): 120-32. Link to SFX for this item
19. Benedetti, F. "Neurobiological mechanisms of the placebo effect." The journal of neuroscience 25.45 (2005): 10390-10402. Link to Full Text for this item Link to SFX for this item
20. Antonini, A. "New strategies in motor parkinsonism." Parkinsonism & related disorders 13.S3 (2007): -9. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.